Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism

  • Technology appraisal guidance
  • TA261
  • Published: 

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: Royal College of Physicians endorse the response by Royal College of Pathologists and British Society for Haematology

This page was last updated: 28 May 2012